《大行報告》大和料中國平安(02318.HK)去年新業務價值按年增32% 淨利潤減少12%
大和發表報告指,中國平安(02318.HK)去年第四季新業務表現疲弱,估計去年新業務價值按年增長32%,去年第四季出現按年倒退,扭轉第二及第三季按年急升76%至79%,主要因為3.5%預定利率壽險產品被監管當局禁售前銷售增加。
該行預期中國平安去年淨利潤按年倒退12%,稅後經營溢利按年跌11%,主要受累於平安銀行(000001.SZ)淨息差收窄,以及費用收入受壓。目前75%銀保業務與平安銀行相關,相信收緊銀保收費,將會推動平保涉足其他銀行渠道。中國平安指引今年新業務價值增長將較同業為佳。
該行維持對中國平安「持有」評級,目標價34元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.